Timothy Daley
Stock Analyst at Wells Fargo
(2.04)
# 3,093
Out of 5,241 analysts
55
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $32.98 | +34.81% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $3.58 | +458.66% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $93.97 | +1.10% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $42.88 | +67.91% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $111.70 | +29.81% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,031.64 | +26.01% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $329.22 | -13.43% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $161.91 | +52.55% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $150.85 | +82.30% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $250.40 | +7.83% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $8.19 | +242.09% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $17.99 | +94.55% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $438.34 | +18.63% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.29 | +2,992.78% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $102.87 | +79.84% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $169.12 | +30.09% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $116.38 | +89.04% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $7.62 | +267.45% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $186.61 | -24.98% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $43.30 | +107.85% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $32.98
Upside: +34.81%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $3.58
Upside: +458.66%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $93.97
Upside: +1.10%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $42.88
Upside: +67.91%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $111.70
Upside: +29.81%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,031.64
Upside: +26.01%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $329.22
Upside: -13.43%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $161.91
Upside: +52.55%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $150.85
Upside: +82.30%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $250.40
Upside: +7.83%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $8.19
Upside: +242.09%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $17.99
Upside: +94.55%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $438.34
Upside: +18.63%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.29
Upside: +2,992.78%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $102.87
Upside: +79.84%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $169.12
Upside: +30.09%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $116.38
Upside: +89.04%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $7.62
Upside: +267.45%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $186.61
Upside: -24.98%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $43.30
Upside: +107.85%